KURA stock news
This page provides real-time market news, earnings updates, and company announcements related to Kura Oncology, Inc. (KURA).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-06-27 06:05 EST
Kura Sushi (KRUS) Q4 2025 Earnings Surpass Expectations, Revenue Grows 20.3% Compared to Last Year
Bitget-RWA2025-11-07 01:58:04
The Cheesecake Factory Earnings: What To Look For From CAKE
Finviz2026-02-17 03:09:42
Earnings To Watch: Texas Roadhouse (TXRH) Reports Q4 Results Tomorrow
Finviz2026-02-18 03:06:36
Earnings Preview: Kura Oncology (KURA) Q4 Earnings Expected to Decline
Finviz2026-02-18 16:04:05
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 12:33:56
Kura Sushi USA to Announce Fiscal Second Quarter 2026 Financial Results on April 7, 2026
Finviz2026-03-17 13:03:53
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 11:33:46
Kura Sushi USA Announces Departure of Chief Financial Officer
Finviz2026-04-07 20:06:10
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
Finviz2026-04-09 11:33:49
Kidney cancer drug data update shows improvement, Kura stock rises
华尔街见闻2026-04-17 15:15:29
「Stock Market Wizard」 Trump's Top 5 Stocks: Accenture, Sushi Brand Make the List, Potential Self-Rescue Situation
BlockBeats2026-05-31 06:07:08
The Nasdaq Biotechnology Index closed down more than 1.8%, with constituent stock Immuneering dropping 22.10%. Nuvalent, Gossamer Bio, Kura Oncology, and Summit Therapeutics Plc. fell between 15.74% and 10.43%, while Grail declined by 10.16%.
华尔街见闻2026-06-02 01:14:42
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 12:33:56
Kura Sushi USA to Announce Fiscal Second Quarter 2026 Financial Results on April 7, 2026
Finviz2026-03-17 13:03:53
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-03 11:33:46
Kura Sushi USA Announces Departure of Chief Financial Officer
Finviz2026-04-07 20:06:10
Kura Oncology to Present Darlifarnib Plus Cabozantinib Data in Patients with Clear Cell Renal Cell Carcinoma Previously Treated with Cabozantinib at IKCS Europe 2026
Finviz2026-04-09 11:33:49
Kidney cancer drug data update shows improvement, Kura stock rises
华尔街见闻2026-04-17 15:15:29
「Stock Market Wizard」 Trump's Top 5 Stocks: Accenture, Sushi Brand Make the List, Potential Self-Rescue Situation
BlockBeats2026-05-31 06:07:08
The Nasdaq Biotechnology Index closed down more than 1.8%, with constituent stock Immuneering dropping 22.10%. Nuvalent, Gossamer Bio, Kura Oncology, and Summit Therapeutics Plc. fell between 15.74% and 10.43%, while Grail declined by 10.16%.
华尔街见闻2026-06-02 01:14:42
KURA stock chart
KURA stock detailsKURA stock price change
On the last trading day, KURA stock closed at 10.36 USD, with a price change of -2.45% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more